Dr Michael Steven Digby, MD | |
1403 Old Water Works Rd Sw, Fort Payne, AL 35968 | |
(256) 979-1250 | |
(256) 979-1251 |
Full Name | Dr Michael Steven Digby |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 16 Years |
Location | 1403 Old Water Works Rd Sw, Fort Payne, Alabama |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871758938 | NPI | - | NPPES |
236661 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 37966 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Renew Family Dermatology | 2466789839 | 4 |
News Archive
The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKETâ„¢ immunotherapy drug candidates to patients in clinical trials beginning in 2019.
Jonathan Teich, M.D., is the Chief Medical Informatics Officer (CMIO) at Elsevier, the world's largest publisher of scientific, technical and medical information. He is also an assistant professor of medicine at Harvard Medical School and a board-certified attending physician in emergency medicine at Brigham & Women's Hospital, Boston.
Researchers from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in Korea have uncovered the mechanisms behind the enzyme that controls our appetite in response to low glucose availability in the brain.
New research from a team of scientists at the Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University in Canada, has aimed to determine the potential causes of anaphylaxis or allergic reactions reported in some individuals after receiving COVID-19 vaccines, including the mRNA vaccines by Pfizer-BioNTech and Moderna.
› Verified 2 days ago
Entity Name | Renew Family Dermatology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275198913 PECOS PAC ID: 2466789839 Enrollment ID: O20190807002884 |
News Archive
The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKETâ„¢ immunotherapy drug candidates to patients in clinical trials beginning in 2019.
Jonathan Teich, M.D., is the Chief Medical Informatics Officer (CMIO) at Elsevier, the world's largest publisher of scientific, technical and medical information. He is also an assistant professor of medicine at Harvard Medical School and a board-certified attending physician in emergency medicine at Brigham & Women's Hospital, Boston.
Researchers from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in Korea have uncovered the mechanisms behind the enzyme that controls our appetite in response to low glucose availability in the brain.
New research from a team of scientists at the Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University in Canada, has aimed to determine the potential causes of anaphylaxis or allergic reactions reported in some individuals after receiving COVID-19 vaccines, including the mRNA vaccines by Pfizer-BioNTech and Moderna.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael Steven Digby, MD 1403 Old Water Works Rd Sw, Fort Payne, AL 35968-3353 Ph: (256) 979-1250 | Dr Michael Steven Digby, MD 1403 Old Water Works Rd Sw, Fort Payne, AL 35968 Ph: (256) 979-1250 |
News Archive
The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKETâ„¢ immunotherapy drug candidates to patients in clinical trials beginning in 2019.
Jonathan Teich, M.D., is the Chief Medical Informatics Officer (CMIO) at Elsevier, the world's largest publisher of scientific, technical and medical information. He is also an assistant professor of medicine at Harvard Medical School and a board-certified attending physician in emergency medicine at Brigham & Women's Hospital, Boston.
Researchers from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in Korea have uncovered the mechanisms behind the enzyme that controls our appetite in response to low glucose availability in the brain.
New research from a team of scientists at the Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University in Canada, has aimed to determine the potential causes of anaphylaxis or allergic reactions reported in some individuals after receiving COVID-19 vaccines, including the mRNA vaccines by Pfizer-BioNTech and Moderna.
› Verified 2 days ago